202 related articles for article (PubMed ID: 24189640)
1. The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.
Forootan FS; Forootan SS; Malki MI; Chen D; Li G; Lin K; Rudland PS; Foster CS; Ke Y
Int J Oncol; 2014 Jan; 44(1):265-75. PubMed ID: 24189640
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
Tölle A; Suhail S; Jung M; Jung K; Stephan C
BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
[TBL] [Abstract][Full Text] [Related]
3. The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Al Fayi MS; Gou X; Forootan SS; Al-Jameel W; Bao Z; Rudland PR; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2016 Dec; 7(50):82783-82797. PubMed ID: 27779102
[TBL] [Abstract][Full Text] [Related]
4. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.
Morgan EA; Forootan SS; Adamson J; Foster CS; Fujii H; Igarashi M; Beesley C; Smith PH; Ke Y
Int J Oncol; 2008 Apr; 32(4):767-75. PubMed ID: 18360704
[TBL] [Abstract][Full Text] [Related]
5. [Expression of peroxisome proliferator-activated receptors, fatty acid binding protein-4 in placenta and their correlations with the prognosis of pre-eclampsia].
Li Y; Chen WL; Liu L; Gu H
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):443-448. PubMed ID: 28797150
[No Abstract] [Full Text] [Related]
6. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity.
Adamson J; Morgan EA; Beesley C; Mei Y; Foster CS; Fujii H; Rudland PS; Smith PH; Ke Y
Oncogene; 2003 May; 22(18):2739-49. PubMed ID: 12743598
[TBL] [Abstract][Full Text] [Related]
8. A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells.
Boiteux G; Lascombe I; Roche E; Plissonnier ML; Clairotte A; Bittard H; Fauconnet S
Int J Cancer; 2009 Apr; 124(8):1820-8. PubMed ID: 19115207
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
Ohlsson G; Moreira JM; Gromov P; Sauter G; Celis JE
Mol Cell Proteomics; 2005 Apr; 4(4):570-81. PubMed ID: 15734831
[TBL] [Abstract][Full Text] [Related]
11. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
13. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription.
Tan NS; Shaw NS; Vinckenbosch N; Liu P; Yasmin R; Desvergne B; Wahli W; Noy N
Mol Cell Biol; 2002 Jul; 22(14):5114-27. PubMed ID: 12077340
[TBL] [Abstract][Full Text] [Related]
14. The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial-to-mesenchymal transition and lipid-derived energy production in prostate cancer cells.
Liu RZ; Choi WS; Jain S; Dinakaran D; Xu X; Han WH; Yang XH; Glubrecht DD; Moore RB; Lemieux H; Godbout R
Mol Oncol; 2020 Dec; 14(12):3100-3120. PubMed ID: 33031638
[TBL] [Abstract][Full Text] [Related]
15. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
[TBL] [Abstract][Full Text] [Related]
16. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Analysis of the
Wang Z; Yue YX; Liu ZM; Yang LY; Li H; Li ZJ; Li GX; Wang YB; Tian YD; Kang XT; Liu XJ
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779219
[TBL] [Abstract][Full Text] [Related]
18. A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.
Bao Z; Malki MI; Forootan SS; Adamson J; Forootan FS; Chen D; Foster CS; Rudland PS; Ke Y
Genes Cancer; 2013 Jul; 4(7-8):297-314. PubMed ID: 24167657
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of osteopontin expression in human prostate cancer.
Forootan SS; Foster CS; Aachi VR; Adamson J; Smith PH; Lin K; Ke Y
Int J Cancer; 2006 May; 118(9):2255-61. PubMed ID: 16331611
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Forootan FS; Forootan SS; Gou X; Yang J; Liu B; Chen D; Al Fayi MS; Al-Jameel W; Rudland PS; Hussain SA; Ke Y
Oncotarget; 2016 Feb; 7(8):9322-39. PubMed ID: 26814431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
